FDA CONDITIONALLY APPROVES ALZHEIMERS DRUG Subject: Science & tech Context: The U.S.’s pharma regulator, the Food and Drug Administration (FDA), made a much anticipated ruling on Monday, in conditionally approving the use of an Alzheimer’s drug, called aducanumab, the first such approval since 2003. Concept: The drug, which goes by the brand name […]